Molecular Mechanisms of Action of Undenatured Type II Collagen: Experimental and Clinical Evidence
In the treatment of joint diseases, including osteoarthritis (OA), the use of standardized extracts of undenatured type II collagen (UDC-II) is promising. It is known that UDC-II is involved in the regulation of innate and adaptive immunity (reduction of autoimmune reactions that stimulate cartilage...
Saved in:
Main Authors: | O. A. Gromova, I. Yu. Torshin, A. M. Lila |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1355 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases
by: O. A. Gromova, et al.
Published: (2022-08-01) -
Biologically active additives in the 21st century: undenatured type II collagen as an example of good medical practice
by: I. S. Dydykina, et al.
Published: (2020-05-01) -
On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2024-08-01) -
Resolution of the Council of Experts “Results of a multicenter, randomized, double-blind, placebo-controlled study of ARTNEO in patients with stage II–III primary knee osteoarthritis”
by: A. M. Lila, et al.
Published: (2023-12-01) -
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01)